Stipanuk Martha H, Londono Monica, Lee Jeong-In, Hu Mindy, Yu Anthony F
Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA.
J Nutr. 2002 Nov;132(11):3369-78. doi: 10.1093/jn/132.11.3369.
In liver, cysteine dioxygenase (CDO), cysteinesulfinate decarboxylase (CSD), and gamma-glutamylcysteine synthetase (GCS) play important regulatory roles in the metabolism of cysteine to sulfate, taurine and glutathione. Because glutathione is released by the liver and degraded by peripheral tissues that express gamma-glutamyl transpeptidase, some peripheral tissues may be exposed to relatively high concentrations of cysteine. Rats were fed diets that contained low, moderate or high concentrations of protein or supplemental cysteine or methionine for 2 wk, and CDO, CSD and GCS activities, concentrations and mRNA levels and the concentrations of cysteine, taurine and glutathione were measured in liver, kidney, lung and brain. All three enzymes in liver responded to the differences in dietary protein or sulfur amino acid levels, but only CSD in kidney and none of the three enzymes in lung and brain responded. Renal CSD activity was twice as much in rats fed the low protein diet as in rats fed the other diets. Changes in renal CSD activity were correlated with changes in CSD concentration. Some significant differences in cysteine concentration in kidney and lung and glutathione and taurine concentrations in kidney were observed, with higher concentrations in rats fed higher levels of protein or sulfur amino acids. In liver, the changes in cysteine level were consistent with cysteine-mediated regulation of hepatic CDO activity, and changes in taurine level were consistent with predicted changes in cysteine catabolism due to the changes in cysteine concentration and CDO activity. Changes in renal and lung cysteine, taurine or glutathione concentrations were not associated with a similar pattern of change in CDO, CSD or GCS activity. Overall, the results confirm the importance of the liver in the maintenance of cysteine homeostasis.
在肝脏中,半胱氨酸双加氧酶(CDO)、半胱亚磺酸脱羧酶(CSD)和γ-谷氨酰半胱氨酸合成酶(GCS)在半胱氨酸代谢生成硫酸盐、牛磺酸和谷胱甘肽的过程中发挥着重要的调节作用。由于谷胱甘肽由肝脏释放并被表达γ-谷氨酰转肽酶的外周组织降解,一些外周组织可能会暴露于相对较高浓度的半胱氨酸中。给大鼠喂食含低、中或高浓度蛋白质或补充半胱氨酸或蛋氨酸的日粮2周,然后测定肝脏、肾脏、肺和脑中CDO、CSD和GCS的活性、浓度和mRNA水平以及半胱氨酸、牛磺酸和谷胱甘肽的浓度。肝脏中的这三种酶均对日粮蛋白质或含硫氨基酸水平的差异做出反应,但肾脏中只有CSD有反应,而肺和脑中的这三种酶均无反应。喂食低蛋白日粮的大鼠肾脏CSD活性是喂食其他日粮大鼠的两倍。肾脏CSD活性的变化与CSD浓度的变化相关。观察到肾脏和肺中半胱氨酸浓度以及肾脏中谷胱甘肽和牛磺酸浓度存在一些显著差异,喂食较高水平蛋白质或含硫氨基酸的大鼠浓度更高。在肝脏中,半胱氨酸水平的变化与半胱氨酸介导的肝脏CDO活性调节一致,牛磺酸水平的变化与由于半胱氨酸浓度和CDO活性变化导致的半胱氨酸分解代谢的预测变化一致。肾脏和肺中半胱氨酸、牛磺酸或谷胱甘肽浓度的变化与CDO、CSD或GCS活性的类似变化模式无关。总体而言,结果证实了肝脏在维持半胱氨酸稳态中的重要性。